[4-(Isopropyl-Methyl-aMino)-piperidin-1-yl]-acetic acid
|
- $1378
- Product name: [4-(Isopropyl-Methyl-aMino)-piperidin-1-yl]-acetic acid
- CAS: 1353973-41-7
- MF: C11H22N2O2
- MW: 214.3
- EINECS:
- MDL Number:MFCD21096736
- Synonyms:[4-(Isopropyl-Methyl-aMino)-piperidin-1-yl]-acetic acid;1-Piperidineacetic acid, 4-[methyl(1-methylethyl)amino]-
4 prices
Selected condition:
Brand
- Chemenu
- Crysdot
Package
- 1g
- ManufacturerChemenu
- Product numberCM497355
- Product description2-(4-(Isopropyl(methyl)amino)piperidin-1-yl)aceticacid 97%
- Packaging1g
- Price$1378
- Updated2026-05-26
- Buy
- ManufacturerChemenu
- Product numberCM497355
- Product description2-(4-(Isopropyl(methyl)amino)piperidin-1-yl)aceticacid 97%
- Packaging1g
- Price$1378
- Updated2026-05-20
- Buy
- ManufacturerCrysdot
- Product numberCD11285326
- Product description2-(4-(Isopropyl(methyl)amino)piperidin-1-yl)aceticacid 97%
- Packaging1g
- Price$1378
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11285326
- Product description2-(4-(Isopropyl(methyl)amino)piperidin-1-yl)acetic acid 97%
- Packaging1g
- Price$1378
- Updated2026-05-26
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Chemenu | CM497355 | 2-(4-(Isopropyl(methyl)amino)piperidin-1-yl)aceticacid 97% | 1g | $1378 | 2026-05-26 | Buy |
| Chemenu | CM497355 | 2-(4-(Isopropyl(methyl)amino)piperidin-1-yl)aceticacid 97% | 1g | $1378 | 2026-05-20 | Buy |
| Crysdot | CD11285326 | 2-(4-(Isopropyl(methyl)amino)piperidin-1-yl)aceticacid 97% | 1g | $1378 | 2021-12-16 | Buy |
| Crysdot | CD11285326 | 2-(4-(Isopropyl(methyl)amino)piperidin-1-yl)acetic acid 97% | 1g | $1378 | 2026-05-26 | Buy |
Properties
Boiling point :323.7±37.0 °C(Predicted)
Density :1.06±0.1 g/cm3(Predicted)
pka :2.47±0.10(Predicted)
Density :1.06±0.1 g/cm3(Predicted)
pka :2.47±0.10(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|




